Abstract
The disappearance rate (k) of i.v. glucose was measured in cachectic and non-cachectic cancer patients and tumour-free controls. The respective k values were found to be 1.06 +/- 0.27 (mean +/- s.d.), 1.64 +/- 0.34 and 1.63 +/- 0.23. Of the other parameters measured, only plasma albumin level was found to vary significantly amongst the 3 categories, the mean level being the lowest in cachectic cancer patients. The means of total plasma protein, fasting blood glucose and plasma liver enzyme concentrations were similar in the 3 groups. Glucagon, a potent insulin secretogogue, failed to augment the fasting insulin level in cachectic but did so in non-cachectic cancer patients. Taken together, the findings suggest that the reduced glucose tolerance in patients with neoplasia is due to impairment of insulin release exhibited predominantly by ill-nourished advanced cancer patients having a moderate to sever degree of hypoalbuminemia.
Citations
Jun 1, 1991·Cancer·L O ByerleyJ Chi
Mar 1, 1983·JPEN. Journal of Parenteral and Enteral Nutrition·J ShearerJ L Mullen
Jun 2, 2020·Acta Physiologica·Stéphanie M L M LooijaardAndrea B Maier
Aug 28, 2020·Frontiers in Oncology·Hannes ZwicklMartin Pecherstorfer
Mar 1, 1990·The British Journal of Surgery·R G Douglas, J H Shaw
Nov 15, 1993·Cancer·A GambardellaM Varricchio
Aug 1, 1992·Journal of the American College of Nutrition·J A Tayek
Mar 28, 2012·Journal of Cachexia, Sarcopenia and Muscle·Mary A Honors, Kimberly P Kinzig
Dec 17, 2014·Nutrition and Cancer·Patrizia MondelloVincenzo Pitini
Jan 31, 2018·Diabetes, Obesity & Metabolism·Anne Cathrine B Thuesen, Allan Vaag
May 5, 2018·BioMed Research International·Jean-Philippe ParvyJulia B Cordero
Oct 9, 2013·Hormones & Cancer·Mary Ann Honors, Kimberly P Kinzig
Nov 1, 1987·The British Journal of Surgery·G P CopelandL J Hipkin
Nov 19, 2020·International Journal of Molecular Sciences·Elisabeth WyartPaolo E Porporato
Apr 4, 2021·International Journal of Molecular Sciences·Steffen H RaunLykke Sylow
May 14, 2021·CA: a Cancer Journal for Clinicians·Daniel R SchmidtJason W Locasale
Jan 1, 1981·The International Journal of Biochemistry·J SinghM P Thompson
Jan 1, 1982·Cancer Letters·E A Zepp
Nov 1, 1983·The American Journal of Medicine·R S RivlinP Sherlock
Feb 1, 1986·Seminars in Oncology Nursing·A M Lindsey
Sep 1, 1979·Cancer Treatment Reviews·M T ShawA J Ladman
Jan 1, 1987·Critical Reviews in Oncology/hematology·J A NortonS D Morrison